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Enterotoxigenic E. coli (ETEC) produce heat-labile (LT) and/or heat-stable (ST)
enterotoxins, and commonly cause diarrhea in resource-poor regions. ETEC
have been linked repeatedly to sequelae in children including enteropathy,
malnutrition, and growth impairment. Although cellular actions of ETEC
enterotoxins leading to diarrhea are well-established, their contributions to
sequelae remain unclear. LT increases cellular cAMP to activate protein kinase
A (PKA) that phosphorylates ion channels driving intestinal export of salt and
water resulting in diarrhea. As PKA also modulates transcription of many
genes, we interrogated transcriptional proﬁles of LT-treated intestinal epithelia. Here we show that LT signiﬁcantly alters intestinal epithelial gene
expression directing biogenesis of the brush border, the major site for nutrient
absorption, suppresses transcription factors HNF4 and SMAD4 critical to
enterocyte differentiation, and profoundly disrupts microvillus architecture
and essential nutrient transport. In addition, ETEC-challenged neonatal mice
exhibit substantial brush border derangement that is prevented by maternal
vaccination with LT. Finally, mice repeatedly challenged with toxigenic ETEC
exhibit impaired growth recapitulating the multiplicative impact of recurring
ETEC infections in children. These ﬁndings highlight impacts of ETEC enterotoxins beyond acute diarrheal illness and may inform approaches to prevent
major sequelae of these common infections including malnutrition that
impact millions of children.

Infectious diarrhea remains a leading cause of death and morbidity
among young children in low-middle-income countries where access
to clean water and sanitation remains in short supply1. Enterotoxigenic
E. coli (ETEC), initially discovered as a cause of severe, cholera-like
illness2, are one of the most common pathogens associated with
moderate-severe diarrhea among children under the age of 5 years3,4,
and are perennially the most common cause of diarrhea in travelers5 to
endemic regions where these organisms are thought to account for
hundreds of millions of cases of diarrheal illness each year6.
Importantly, ETEC infections have been linked to non-diarrheal
sequelae, including “environmental enteric dysfunction (EED),” a
condition characterized by impaired nutrient absorption, impaired

growth7,8, and malnutrition9,10, adding signiﬁcantly to the morbidity as
well as deaths from diarrhea and other infections11. The risk of stunting
multiplies with each episode of diarrheal illness in children under the
age of two years12, a period during which children residing in impoverished areas commonly sustain multiple ETEC infections8. However,
the molecular pathogenesis underlying the intestinal changes associated with EED, and the contribution of individual pathogens,
including ETEC, remain poorly understood.
Similarly, toxin-producing E. coli have also been repeatedly identiﬁed in patients with tropical sprue13–15, a condition classically described in adults residing for extended periods of time in areas where
ETEC diarrheal disease is common. Like EED, tropical sprue is
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ciated LT-producing ETEC with undernutrition27, suggesting that heatlabile toxin may exert effects on intestinal mucosa that extend beyond
acute diarrheal illness.
Here we demonstrate that in addition to the canonical effects of
LT on the cellular export of salt and water into the intestinal lumen, this
toxin impacts multiple genes involved in the formation of microvilli,
resulting in marked alteration of the architecture of the intestinal
brush border, the major site of nutrient absorption in the small
intestine. These effects are compounded by the alteration of solute
transporters within the brush border epithelia, potentially disrupting
the absorption of multiple essential nutrients.

associated with changes to the small intestinal villous architecture,
including ultrastructural alteration of the epithelial brush border
formed by the microvilli16,17, nutrient malabsorption, and wasting.
The basic molecular mechanisms underpinning acute watery
diarrhea caused by ETEC are well-established18. ETEC produces heatlabile (LT) and/or heat-stable (ST) enterotoxins that activate the production of cAMP and cGMP second messengers, respectively, leading
to activation of cellular kinases that in turn modulate the activity of
sodium and chloride channels in the apical membrane of intestinal
epithelial cells to promote net efﬂux of salt and water into the intestinal lumen resulting in watery diarrhea.
LT and cholera toxin (CT) share ~85% amino acid identity, and
both toxins exert their major effects on the cell through the ADPribosylation of the alpha subunit of Gs (Gsα), a stimulatory intracellular
guanine nucleotide-binding protein. Inhibition of Gsα GTPase activity
leads to constitutive activation of adenylate cyclase and increased
production of intracellular cAMP19.
In its central role as a second messenger, cAMP governs a diverse
array of cellular processes20 and modulates the transcription of multiple genes through a number of cAMP-responsive transcriptional
activators and repressors21. cAMP activates protein kinase A (PKA), a
heterotetramer, by liberating its two regulatory subunits from the
catalytic subunits, which are then free to phosphorylate a wide variety
of cytoplasmic and nuclear protein substrates22. PKA largely regulates
transcription by phosphorylation of transcription factors, including
the cyclic AMP response element binding protein (CREB) and the
cAMP-response element modulator (CREM), which bind cAMPresponse elements (CRE) in the promoter regions of target genes21–23.
Notably, cholera toxin (CT), LT, and dibutyryl-cyclic AMP all
induce hypersecretion and impact the architecture of gastrointestinal
epithelia in rodent small intestine24, while small intestinal biopsies of
patients with acute cholera exhibit marked changes in the ultrastructure of the intestinal brush border, the major absorptive surface
in the small intestine25,26, including shortening and disruption of the
microvilli. Consistent with these observations, studies of young children less than two years of age in Bangladesh have speciﬁcally asso-

Results
Heat-labile toxin markedly alters the transcriptomes of
intestinal epithelial cells
Commensurate with the importance of cAMP as a second messenger,
we found that compared to either untreated controls or cells treated
with a catalytically inactive (E211K) mutant of LT, wild-type LT holotoxin substantially modulated transcription of many genes in intestinal
epithelial cells. In RNA-seq studies of polarized Caco-2 intestinal epithelial cells, we found that 3832 genes were signiﬁcantly (p ≤ 10−5)
upregulated and 3687 downregulated in response to LT, while the
inactive toxin failed to induce signiﬁcant changes in the transcriptome
(Fig. 1a). However, Caco-2 cells are derived from distant metastases of a
colon cancer tumor in which transcriptomes would likely be altered
relative to untransformed intestinal epithelia28,29, and cAMP signaling is
known to be aberrant in some transformed cells23. Therefore, to
examine a more physiologically relevant target, we next examined the
impact of LT on differentiated small intestinal enteroids. Here, we
found that far fewer genes were differentially expressed (≤10−5), with
746 signiﬁcantly upregulated, and 561 downregulated in response to
intoxication with LT (Fig. 1b). Notably, however, we found substantial
statistically signiﬁcant overlap in genes signiﬁcantly modulated in
Caco-2 cells and enteroids (Supplementary Table 3 and Supplementary
Dataset 1) with the transcription of hundreds of genes signiﬁcantly upor down-regulated in both groups. Gene ontology enrichment analysis,
b
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Fig. 1 | Heat-labile toxin modulates expression of multiple genes in intestinal
epithelia. Model at left depicts the E. coli heat-labile toxin92 based on PDB structure
1LTS with the A1 subunit in blue, the A2 region in yellow, and pentameric B subunit
in green. The E211K mutation of mLT is in the active site of the A1 subunit.
a Scatterplot of RNAseq data right depicts differential expression proﬁles of Caco-2
cells following exposure to a heat-labile toxin (n = 2) relative to untreated cells
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Fig. 2 | Heat-labile toxin modulates multiple genes involved in microvillus
assembly. a Diagram at the top (adapted from ref. 30) depicts molecules involved
in key elements of microvillus development. b Heatmaps of RNA-seq data obtained
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independent samples) or LT (n = 2) relative to untreated cells (n = 2); and ileal
enteroids (right) treated with LT (n = 3) relative to control untreated cells (n = 3).
Comparisons were made with DESeq293. Bars indicate absolute log2 fold change
values + SE. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 10−4, and *****p ≤ 10−5.

as well as ontology-independent investigation of genes (CompBio,
Supplementary Fig. 1) modulated by the toxin, highlighted multiple
cellular components associated with both the development and
function of the absorptive surface of the small intestine (Supplementary Dataset 2).

small intestinal enteroids (Fig. 3b and Supplementary Fig. 2). In
addition, TEM images of polarized small intestinal enteroids
exposed to heat-labile toxin demonstrated signiﬁcantly shortened
and disorganized microvillus structures on the apical surface of
enterocytes (Fig. 3c).

Heat-labile toxin impairs the development of small intestinal
microvilli

Heat-labile toxin modulates the transcription of multiple brush
border nutrient transport genes

Small intestinal enterocytes are each covered with hundreds of
microvilli, complex structures comprised of a central core of actin
ﬁlaments within protrusions of the plasma membrane. Collectively,
the luminal surface of the intestine formed by these microvilli,
known as the brush border, represents the major absorptive surface
of the gastrointestinal tract. Three major classes of proteins are
required for the biogenesis of microvilli30 (Fig. 2a). These include (1)
proteins such as villin, epsin, plastin, and EPS8 that bundle parallel
clusters of actin ﬁlaments; BAIP2L1 (IRTKS) responsible for
recruiting the EPS bundling protein to the tips of microvilli31; (2)
ezrin, myo1a32, myo6 that link the actin cytoskeleton with the
plasma membrane; and (3) protocadherin molecules CDHR2 and
CDHR5 engaged in extracellular heterotypic complexes between
the tips of the microvilli30 that are stabilized by a tripartite complex
of MYO7B, ANKS4B33, and USH1C33. Interrogation of transcriptional
proﬁles indicated that the transcription of each of these classes of
genes was signiﬁcantly altered following exposure to wild-type
heat-labile toxin (Fig. 2b). Similarly, RT-PCR conﬁrmed decreased
expression of multiple genes involved in microvilli biogenesis,
including VIL1 encoding villin (Fig. 3a), and we were able to
demonstrate that production of villin was depressed in polarized

The human solute carrier (SLC) gene superfamily is comprised of more
than 50 gene families thought to encode more than 300 functional
transporters34. Many of the SLC proteins are enriched in the small
intestinal brush border, where they transport critical nutrients,
including amino acids, oligopeptides, sugars, and vitamins. We found
that transcription of many SLC genes was altered in Caco-2 cells as well
as small intestinal enteroids (Fig. 4a). These included transporters for
Zinc, known both to be deﬁcient in children with enteropathy35, and a
micronutrient critical for intestinal homeostasis. Likewise, transcription of SLC19A3 encoding the principal SLC responsible for uptake of
the water-soluble B vitamin thiamine (vitamin B1)36 by differentiated
intestinal epithelial cells lining the surface of intestinal villi of the
proximal small intestine37,38 (Fig. 4b) was repressed as was the production of the corresponding protein (supplementary ﬁgure 3a).
Moreover, we found that LT treatment of human small intestinal
organoids also interfered with the transcription of the cis-regulatory
element speciﬁcity protein 1 (SP1) previously shown to govern the
transcription of SLC19A339–41 (Fig. 4c and Supplementary Fig. 3b).
Finally, we found that thiamine transport was signiﬁcantly depressed
following exposure to LT (Fig. 4d) providing additional evidence that
ETEC can impair transport of critical nutrients.
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Fig. 3 | Heat-labile toxin impairs the effective formation of small intestinal
microvilli. a Quantitative RT-PCR data from n = 9 biologically independent samples
for selected microvillus genes comparing untreated (−) and LT-treated (+) ileal
epithelial cells (enteroid line 235D). b Villin production is suppressed in small
intestinal enteroids following treatment (t + 18 h) with LT (100 µg/ml). Shown are
representative confocal images obtained showing membrane (CellMask, blue),
nuclei (white), villin (gold), and merged image. The graph at right shows apical villin
geometric mean ﬂuorescence intensity data relative to the corresponding

cytoplasmic signal. Each symbol (n = 12) represents a unique region of interest. For
a, b ****p < 0.0001, ***p < 0.001 by Mann–Whitney two-tailed testing. c TEM images
of small intestinal microvilli following treatment LT (right) compared to control
untreated cells (left). The graph at right shows the length of microvilli when
enteroids (n = 2 biologically independent samples) are treated before (pre) and
after (post) differentiation on polarized ileal cells ****<0.0001 by ANOVA
(Kruskal–Wallis, nonparametric testing).

LT-producing ETEC disrupts the absorptive architecture of the
small intestine

Despite the dramatic toxin-dependent changes to the absorptive
surface of the intestine, the early growth kinetics of suckling mice
challenged a single time with either wild-type bacteria or a heat-labile
toxin deletion mutant were surprisingly similar (Supplementary
Fig. 5A) and paralleled those of sham-challenged controls. However,
enteropathy in young children is thought to reﬂect damage elicited by
repeated infections. Children in endemic regions typically suffer multiple ETEC infections before their second birthday, and the risk of
enteropathic sequelae increases multiplicatively per episode8,12.
Therefore, to assess the contribution of repeated ETEC infections to
growth impairment, we compared the growth kinetics of suckling mice
challenged a single time to those repeatedly infected with wild-type
toxigenic ETEC. These studies demonstrated a clear impact of repeated infection on growth (Supplementary Fig. 5B). Finally, we found
that the growth kinetics of mice repeatedly challenged with wild-type
ETEC H10407 was signiﬁcantly retarded relative to those challenged
with the isogenic LT-mutant jf876 (Supplementary Fig. 5C). Therefore,
repeated infections in this model appear to recapitulate impacts
observed following repeated ETEC infection in children, and our data
suggest that these features are at least in part driven by LT.

To further study the potential impact of ETEC toxins on intestinal
architecture, we performed challenge studies in infant mice. Compared to sham-challenged (PBS) controls, or mice challenged with a
toxin-deﬁcient strain of ETEC, we again noted down-regulation of
genes involved in F-actin bundling, membrane cross-linking, and
intermicrovillus adhesion complex formation, all required for
intestinal microvilli (Fig. 5a) biogenesis. Likewise, on examination of
small intestinal villi we found that the production of villin in
enterocyte brush borders was substantially decreased relative to
sham-challenged controls (Fig. 5b, c). In mice challenged with a
wild-type ETEC isolate that makes ST and LT, but not an LT/ST-toxinnegative mutant (jf4763, Supplementary Table 1), we observed
signiﬁcant alteration in the architecture of the intestinal brush
border with signiﬁcant shortening and disorganization of the
microvilli (Fig. 5d, e and Supplementary Fig. 4a–d) reminiscent of
the earlier ultrastructural studies of patients with tropical sprue17
and V. cholerae infections25. Similarly, we found that in mice challenged with a strain containing an isogenic mutation in eltA (jf571,
Supplementary Table 1) encoding the LT A subunit, which still
makes heat-stable toxins, the microvillus architecture was preserved (Fig. 5f, g), suggesting that LT is the principal toxin underlying the enteropathic changes to the enterocyte surfaces.
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Fig. 4 | Heat-labile toxin alters the transcription of multiple brush border SLC
genes. a Heatmap indicating key SLC genes modulated by heat-labile toxin (LT)
compared to enzymatically inactive E112K LT mutant (mLT), or untreated (ø) Caco2 cells (left) and human small intestinal (ileal) enteroids (Hu235D, right). Bars
indicate absolute log2 fold change values + SE. Comparisons were made with
DESeq293. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 10−4, *****p ≤ 10−5. Real-time qRT-

PCR conﬁrming LT-mediated modulation of genes in ileal (Hu235D) enteroids
encoding b the major thiamine transporter SLC19A3 and c the SP1 cis-regulatory
element. Data reﬂect two independent experiments with two replicates each.
d Uptake of [3H]-thiamine by Hu235D cells is impaired following LT treatment. Data
presented in b–d are from two independent experiments with n = 3 replicates each.
(*<0.05, **<0.01 by Mann–Whitney two-tailed comparisons).

vaccinated mouse dams with heat-labile toxin and examined the brush
border ultrastructure in suckling mice. Vaccinated dams but not sham
vaccinated controls expressed signiﬁcant levels of IgA and IgG in
breast milk (Fig. 6a), consistent with increased levels of antibodies in
the stomachs of infant mice (Fig. 6b). Notably, we found that maternal
vaccination with LT completely abrogated changes to the microvilli
(Fig. 6c, d) further substantiating the importance of LT in driving
changes to the epithelial architecture.

treated cells (Fig. 7c), suggesting that activation of cAMP can interfere
with transcription mediated by HNF4. To further examine the impact
of LT on HNF4-mediated transcription, we introduced a transcriptional
reporter plasmid containing six tandem copies of the HNF4 transcriptional response element (5′-CAAAGGTCA-3′) linked to a human
codon-optimized Gaussia princeps luciferase into Caco-2 cells. These
assays demonstrated that HNF4-mediated transcription was dramatically reduced in cells treated with LT (Fig. 7d). Similarly, we found that
relative to nuclei of intestinal epithelial cells in ileal segments from
sham-challenged control mice, those from ETEC-challenged mice
exhibited signiﬁcantly less HNFγ (Fig. 7e) further supporting a role for
ETEC in modulating the production of this important transcription
factor. Chen et al described a “feed-forward regulatory module”
essential to enterocyte differentiation in which HNF4 and SMAD4
transcription factors reciprocally activate each other’s transcription.
As would be predicted from this model, we found that transcription of
SMAD4 was also impaired by LT (Supplementary Fig. 6A, B), leading us
to speculate that LT-mediated phosphorylation of HNF4 by PKA,
interrupts this critical transcription module (Supplementary
Fig. 6C–E).
Collectively, the current studies demonstrate that in addition to
their known canonical effects on ion transport that culminate in watery
diarrhea, ETEC toxins can drive appreciable derangement of enterocyte architecture and function by interfering with key pathways in
intestinal epithelia that govern the formation of mature enterocytes
capable of effective nutrient absorption. These ﬁndings have important implications for our understanding and prevention of enteropathic conditions linked to ETEC.

LT modulates key transcription factors that govern enterocyte
development
Despite the marked alteration in transcription mediated by LT, the
majority of genes critical for brush border development lacked
conserved CRE sites23. Therefore, we performed transcription factor
target enrichment analysis42,43 to identify potential transcription
factors responsible for differential regulation of genes signiﬁcantly
(P < 0.05) upregulated or downregulated by LT in both Caco-2 and
enteroid RNA-seq datasets (Supplementary Table 4 and Supplementary Dataset 1). The upregulated genes were most signiﬁcantly
(p = 4.2 × −10−3) linked to transcription factor targets of AP-1 encoded by the c-jun gene, previously shown to be regulated by cAMP44,
and to be involved in intestinal epithelial repair45. Notably, however,
downregulated genes were most signiﬁcantly enriched in targets for
the HNF4α transcription factor or its intestine-speciﬁc paralog
HNF4γ (P = 1.9 × −10−4) that were recently shown to regulate multiple genes required for brush border development46,47. Importantly,
PKA has also been shown to phosphorylate HNF4 α at a consensus
recognition site within the DNA binding domain, shared with HNF4
γ, inhibiting transcription48.
Of note, the transcription of both paralogs was found to be signiﬁcantly depressed following exposure of intestinal epithelia to LT
(Fig. 7a, b), as were levels of HNF4γ in nuclear fractions from toxin-
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be key to the effective design of prevention strategies, including
vaccines49. Although the molecular mechanisms involved in the
ﬂuid and ion ﬂuxes into the intestinal lumen leading to diarrhea are
ﬁrmly established, only recently has evidence emerged to suggest
that ETEC toxins may incite previously unappreciated changes in
small intestinal epithelia50,51. The present studies, initiated to identify additional effects of LT, were prompted by an appreciation that
cyclic nucleotides, particularly cAMP, govern a multitude of cellular
pathways, potentially resulting in collateral impacts that extend

beyond the acute episodes of diarrhea. Consistent with this model,
we found that exposure of intestinal cells to heat-labile toxin altered
the transcription of hundreds of genes. A central theme highlighted
in the analysis of these transcriptional alterations is that LT affects
major classes of genes involved in the biogenesis of microvilli and
the function of the intestinal brush border, the major site of nutrient uptake in the small intestine, potentially offering a direct
molecular link to sequelae of malnutrition and impaired growth in
children.
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****p < 0.0001 by Mann–Whitney two-tailed comparisons. c Representative transmission electron microscopy images of brush border microvilli from unvaccinated
mice challenged with wild-type ETEC (left), vaccinated mice challenged with wildtype ETEC, and vaccinated un-challenged controls. d Microvillus lengths (based on
image analysis of n = 5 mice group) ****<0.0001 Kruskal–Wallis comparisons.

The potential clinical relevance of the observations reported here
is highlighted by remarkably similar ultrastructural alteration of
intestinal epithelial cells seen in small intestinal biopsies of patients
with acute cholera25 and tropical sprue17. In both entities, the brush
border was noted to be abnormal, with shortened, irregular microvilli.
Importantly, however, despite the structural and functional similarity
between LT and CT, clinical cholera, unlike ETEC infections, has not
been linked to enteropathy or attendant sequelae. Whether this relates
to the repetitive nature of ETEC infections compared to the durable
protective immunity that follows a single V. cholerae infection52 is not
presently clear. Similarly, while tropical sprue remains a leading cause
of malabsorption in regions where infectious diarrhea is prevalent53–55,
the most debilitating forms of this illness have not typically followed
isolated cases of traveler’s diarrhea, but occur in resident populations
or expatriates56 repeatedly assailed by diarrhea while residing in
endemic regions57. Likewise, our data also highlight the potential
importance of repeated infections on the development of sequelae.
The negative impacts of LT on brush border architecture, with a
commensurate reduction in surface area available for nutrient
absorption, are compounded by the alteration of multiple SLC genes
that encode transporters critical for the uptake of essential vitamins
and other molecules. Importantly, small intestinal biopsies obtained
from Zambian children with enteropathy and refractory stunting
exhibited similar changes in SLC gene expression proﬁles58. The
decreased transcription of molecules required for intestinal zinc
uptake, in cells treated with LT is particularly intriguing given the
known aberrations in zinc absorption in children with
enteropathy35,59,60, the possible contribution of zinc deﬁciency to
enteropathic changes61, and the salutary effects of zinc in the treatment of children with diarrhea62,63.
Further study will be needed to precisely delineate the role of
ETEC LT and ST enterotoxins, alone and in combination, in driving
enteropathic changes to the intestine and sequelae. ST-producing
ETEC were most strongly associated with moderate to severe diarrhea
in GEMS3, and follow-on studies of children enrolled in these studies

have also linked infections with ETEC encoding heat-stable toxin to
growth faltering7. However, our earlier analysis of a global collection of
more than 1100 ETEC isolates, including those collected in GEMS,
demonstrated that slightly more than half of all ST-encoding strains
also encoded LT, and that roughly one-third of the isolates overall
encoded LT alone, ST-LT, or ST only64. While LT-producing ETEC have
been speciﬁcally linked to malnutrition among children in
Bangladesh27, and our in vitro and animal studies point to the potential
importance of LT, additional effort will be needed to correlate toxininduced morphologic and functional perturbation of the intestinal
brush border with outcomes in children. Importantly, the long-term
morbidity associated with ETEC infections does not appear to correlate with the severity of diarrhea as both mild illness4, and perhaps
asymptomatic colonization may lead to growth faltering.
Further reﬁnement of animal models that can faithfully recapitulate features of enteropathy are also needed. Indeed, conventional
mice lack genes that could be required to reproduce the full effects of
ETEC. For instance, each of the carcinoembryonic antigen cell adhesion molecules (CEACAMs) that are substantially upregulated on
human small intestinal epithelia in response to LT, and which we have
recently shown to play a critical role in ETEC interactions with human
small intestine50, are absent in mice.
While the precise mechanism underlying LT-mediated modulation of genes required for microvillus biogenesis and absorptive
function of the brush border is presently unclear, stimulation of adenylate cyclase invokes many cAMP-responsive nuclear factors that may
serve either to activate or repress transcription. Genes implicated in
the development of microvilli are mostly devoid of consensus palindromic (TGACGTCA) or “half” (CGTCA) cAMP-response element (CRE)
sites within their promoter regions for direct modulation by CREB65,
which typically is involved as a transcriptional activator, and both
CREB and CREM can yield several alternatively spliced variants that
may act as either activators or repressors66. cAMP second messaging
also engages multiple signaling pathways converging at CREB67, and
PKA can phosphorylate and modulate the activity of multiple
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Fig. 7 | Enterotoxigenic E. coli heat-labile toxin impairs production of HNF4
nuclear receptors. a Heatmap demonstrating the impact of LT on transcription of
paralogous transcription factors HNF4α and HNF4γ in Caco-2 cells (left) and ileal
enteroids, (Hu235D, right) ø untreated, mLT mutant LT. b qRT-PCR (TaqMan) data
conﬁrming decreased transcription of HNF4 transcription factors following
treatment of enteroids with LT (n = 9 biologically independent samples).
****<0.0001 by Mann–Whitney two-tailed comparisons. c HNF4γ is decreased in
nuclear fractions obtained from small intestinal enteroids following treatment with
LT. Shown in the HNF4γ immunoblot are samples from four independent experiments, with the graph below-representing quantitation of signal intensity normalized to the lamin B1 nuclear protein (p = 0.0017, paired t-test, one-tailed). Bars

indicate mean ± 95% conﬁdence intervals. d HNF4 transcription Gaussia luciferase
reporter assay showing a decrease in signal following treatment of TR104transfected Caco-2 cells with LT. 2 experimental replicates (n = 15 samples total)
***p < 0.001 Wilcoxon matched pairs, one-tailed). e Confocal microscopy of
representative Ileal sections from sham-challenged (PBS) left, and ETEC-infected
mice (right). Immunoﬂuorescence intensity of HNF4γ signal in sections from n = 5
control mice, and n = 6 ETEC-challenged mice. Membranes (yellow) were strained
with CellMask orange (Thermo Fisher C10045), nuclei (blue) were stained with
DAPI, and HNFγ immunostaining was represented in white. Each symbol represents
a microscopic region of interest. Bars represent geographic means (p < 0.0001,
Mann–Whitney two-tailed comparisons).

transcription factors to act either as transcriptional activators or
repressors, including SP168. Notably, putative binding sites for HNF4, a
cAMP-modulated transcription factor48 known to regulate genes needed for the formation of microvilli46,47, were signiﬁcantly enriched in
the promotors of genes downregulated by LT. Both HNF4α and HNF4γ
possess canonical PKA recognition sites within their DNA binding
motifs, and PKA phosphorylation of these sites interrupts
transcription69. HNF4 activates the transcription of SMAD4, and in
turn, SMAD4 activates the transcription of HNF470. Both transcription
factors then engage genes needed for the effective differentiation of
stem cells to mature enterocytes70. Modulation of the activity of this
transcription factor by LT would therefore be predicted to have a
marked impact on pathways critical to intestinal epithelial
homeostasis.
We should also note that increases in cellular cAMP can impact
multiple cellular pathways independent of PKA. Included among these
are pathways governed by a more recently discovered family of cellular
cAMP-binding molecules, exchange proteins activated by cAMP
(EPACs). EPACs appear to play critical roles as guanine exchange factors that regulate GTPase proteins71 and are involved in complex signaling networks implicated in cell growth, differentiation, and
morphogenesis72,73.
cAMP can also exert potent epigenetic inﬂuences on transcription. CREB-binding protein (CBP) possesses intrinsic histone acetyltransferase (HAT) activity74, and can therefore modulate chromatin

remodeling, enhancing access to transcription factors. In addition,
cAMP messaging through PKA leads to phosphorylation-dependent
activation of the histone demethylase enzyme PHF2 to promote the
transcription of multiple genes that can impact the transition from
stem cells to epithelial cells75.
Increased intestinal permeability is a recognized hallmark of
enteropathy in young children in LMICs76. Given the known negative
impacts of cholera toxin on epithelial barrier function77, and its
structural and functional similarity to a heat-labile toxin, LT may exert
additional enteropathic effects beyond the impact on brush border
biogenesis described here.
Altogether it seems likely that multiple pathways governed by
increases in cellular cAMP may underlie the morphologic and functional disruption of the brush border epithelial observed in our studies. Nevertheless, the data presented here provide compelling
evidence that the heat-labile toxin of ETEC ultimately impacts multiple
genes required for the biogenesis and function of the brush border,
the major site of nutrient absorption in the human small intestine. The
ﬁndings may have signiﬁcant implications for our understanding of
sequelae linked to ETEC, including environmental enteropathy in
young children, and tropical sprue in adults. The increased acknowledgement of long-term morbidity linked to ETEC and an improved
understanding of the role of ETEC enterotoxins as drivers of this
morbidity may also strengthen the case for vaccines49 speciﬁcally
engineered to prevent both acute illness and sequelae.
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Methods
The studies reported here comply with all relevant ethical regulations
and the study protocols have been approved by the IACUC, Institutional Biosafety, and Institutional Review Boards at Washington University in Saint Louis School of Medicine.

Culture and differentiation of enteroids
Archived small intestinal enteroid specimens derived from biopsy
samples of adult patients undergoing routine endoscopy were
obtained from the Organoids Core of the Digestive Disease Research
Core Center (DDRCC) at Washington University School of Medicine
under Institutional Review Board (IRB) protocol number 201406083.
Cell lines used in these are routinely validated for response to the heatlabile toxin by cAMP assays (Arbor Assays, Ann Arbor, MI).
Puriﬁed crypt cells from the ileum (Hu235D) were resuspended in
Matrigel (BD Biosciences, San Jose, CA, USA) and 15 µL of resuspended
matrix gel was added to each well in 24 well plates. Plates were incubated at 37 °C and 5% CO2 with 50% L-WRN conditioned media (CM)
and 50% primary culture medium (Advanced DMEM/F12, Invitrogen)
supplemented with 20% FBS, 2 mM L-glutamine, 100 units/mL penicillin, 0.1 mg/mL streptomycin, 10 µM Y-27632 (ROCK inhibitor, Tocris
Bioscience, R&D systems, Minneapolis, MN, USA), and 10 µM SB431541
(TGFBR1 inhibitor, Tocris Bioscience, R&D systems).
To induce differentiation and polarization of enteroids, cells were
washed once to remove Matrigel, followed by trypsinization and centrifugation at 1100 × g for 5 min. Cells were then resuspended in 1:1 CM
and primary medium with Y-27632 and SB431541 as described above.
Cells were then plated on semiporous ﬁlters (Transwells®, 6.5 mm
insert, 24 well plate, 0.4-μm polyester membrane, Corning Incorporated, Kennebunk, ME, USA) that had been previously coated with
Collagen IV (Millipore Sigma). Transwell® inserts were rinsed with
DMEM/F12 with Hepes, 10% FBS, L-glutamine, Penicillin, and streptomycin. Cells were allowed to grow to conﬂuency in 50% conditioned
media (CM) and then changed to a differentiation medium (5% CM in
primary medium + ROCK inhibitor) for 48 h. Differentiated cells were
used for toxin treatment.

Propagation of Caco-2 cells
Caco-2 intestinal epithelial cells were obtained from ATCC (ATCC HTB37) and cultured at 37 °C, 5% CO2, in Eagle’s MEM supplemented with
20% of fetal bovine serum (FBS). To generate polarized monolayers,
~1 × 105 cells were seeded onto polystyrene membrane ﬁlters (0.4 μM,
6.5 mm diameter insert, Transwell, Corning) and grew for at least a
week prior to toxin treatment. Media was replaced with fresh media
every two days.

Toxin treatment
Polarized differentiated cells were treated with a heat-labile toxin (LT)
in a differentiation medium (100 ng/mL) in a volume of 700 µL at the
basolateral side of the Transwell insert and 100 µL volume on the apical
aspect of the monolayer. Treated cells were incubated at 37 °C for 18 h
and then ﬁxed for transmission electron microscopy or ﬂuorescence
microscopy, or lysed for RNA extraction (GE Healthcare, Buckinghamshire, UK). LT and mutant LT (E211K, mLT) were kindly provided by Dr. John D. Clements, Tulane University, New Orleans,
Louisianna, USA.

RNA extraction and cDNA synthesis
RNA was extracted using the Illustra RNAspin Mini RNA extraction
kit (GE Healthcare, Buckinghamshire, UK). Three biological replicates per treatment (untreated and LT treated) were submitted to
the Genome Technology Access Center (GTAC) at Washington
University in St. Louis School of Medicine for RNA-seq library preparation. An Agilent Bioanalyzer was used to determine the integrity of RNA samples. cDNA was generated using SuperscriptTM ViloTM
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cDNA synthesis kit (Invitrogen by Thermo Fisher) after normalizing
RNA concentrations.

RNA-seq library preparation
Library preparation was performed with 10 ng of total RNA, integrity
was determined using an Agilent bioanalyzer. ds-cDNA was prepared
using the SMARTer Ultra Low RNA kit for Illumina Sequencing (Clontech) per the manufacturer’s protocol. cDNA was fragmented using a
Covaris E220 sonicator using peak incident power 18, duty factor 20%,
cycles/burst 50, and time 120 s. cDNA was blunt-ended, had an A base
added to the 3′ends, and then had Illumina sequencing adapters ligated to the ends. Ligated fragments were then ampliﬁed for 12–15 cycles
using primers incorporating unique index tags. Fragments were
sequenced on an Illumina HiSeq-2500 using single reads extending
50 bases.

RNA-seq data processing and analysis
RNA-seq reads were aligned to the Ensembl top-level human genome
assembly with STAR version 2.7.3a. Gene counts were derived from the
number of uniquely aligned unambiguous reads by Subread:featureCount version 1.54.1. Read counts were used as input for DESeq2 differential gene expression analysis (version 1.24.0)78 with default
settings, and a minimum P value signiﬁcance threshold of 10−5 (after
false discovery rate [FDR79] correction for the number of tests). Fragments per kilobase per million reads mapped (FPKM) values for relative gene expression were calculated from DESeq2-normalized read
counts, and Z-scores were calculated per gene using the average and
standard deviations of FPKM values across samples. Log2 fold changes
were identiﬁed from differential expression output. Pathway enrichment analysis for KEGG80 and Gene Ontology (GO)81 pathways among
gene sets of interest was performed using the over-representation
analysis tool provided on the WebGestalt42 web server (version 2019).
Heatmap and bar graph visualization was performed with
Microsoft Excel.
Transcript counts were produced by Sailﬁsh version 0.6.3.
Sequencing performance was assessed for the total number of aligned
reads, the total number of uniquely aligned reads, genes and transcripts detected, ribosomal fraction known junction saturation, and
read distribution over known gene models with RSeQC version 2.3.
All gene-level and transcript counts were then imported into the
R/Bioconductor package EdgeR and TMM normalization size factors
were calculated to adjust for samples for differences in library size.
Ribosomal features, as well as any feature not expressed in at least the
smallest condition size minus one sample were excluded from further
analysis and TMM size factors were recalculated to created effective
TMM size factors. The TMM size factors and the matrix of counts were
then imported into R/Bioconductor package Limma and weighted
likelihoods based on the observed mean-variance relationship of every
gene/transcript and sample were then calculated for all samples with
the voomWithQualityWeights function. The performance of the samples was assessed with a spearman correlation matrix and multidimensional scaling plots. Gene/transcript performance was assessed
with plots of the residual standard deviation of every gene to their
average log count with a robustly ﬁtted trend line of the residuals.
Generalized linear models were then created to test for gene/transcript level differential expression. Differentially expressed genes and
transcripts were then ﬁltered for FDR-adjusted p values less than or
equal to 0.05.
The biological interpretation of the large set of features found in
the Limma results were then elucidated for global transcriptomic
changes in known Gene Ontology (GO) and KEGG terms with the R/
Bioconductor packages GAGE and Pathview. Brieﬂy, GAGE measures
for perturbations in GO or KEGG terms based on changes in observed
log2 fold changes for the genes within that term versus the background
log2 fold changes observed across features not contained in the
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respective term as reported by Limma. For GO terms with an adjusted
statistical signiﬁcance of FDR ≤0.05, heatmaps were automatically
generated for each respective term to show how genes co-vary or coexpress across the term in relation to a given biological process or
molecular function. In the case of KEGG-curated signaling and metabolism pathways, Pathview was used to generate annotated pathway
maps of any perturbed pathway with an unadjusted statistical signiﬁcance of p value ≤0.05. Genes signiﬁcantly modulated in both Caco2 cells and enteroids were subjected to further ontology-free analysis
via CompBio v1.4 (PercayAI, Inc., www.percayai.com/compbio)82 to
identify unifying biological themes in sets of genes differentially
expressed between pairwise comparisons of different groups.
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different approaches that include overexpression of tagged protein or
gene silencing85. Anti-SP1 antibodies were validated by the manufacturer using knockout cell lysate protein samples. The SLC19A3 and
SP1 protein bands from the blot were then identiﬁed with corresponding anti-rabbit IR-800 dye (1:30,000; Cat# 926-32211; LI-COR
Bioscience) and anti-mouse IR-680 dye (1:30,000; Cat# 926-68020; LICOR Bioscience) secondary antibodies incubation for 1 h at room
temperature. Relative expression of speciﬁc proteins was calculated by
comparing the ﬂuorescence intensities in an Odyssey infrared imaging
system (LI-COR Bioscience) with respect to the corresponding betaactin signal.

Quantitative real-time PCR was performed using a QuantStudio 3 realtime detection system (Applied Biosystems). Fast SYBR Green master
mix (Applied Biosystems/Thermo Fisher) was used for qPCR analysis.
Disassociation curve analysis was performed to assess the speciﬁcity of
ampliﬁcation for each sample, and PCR product size was veriﬁed by
agarose gel electrophoresis. Percent expression was normalized by
GAPDH and analyzed using the comparative threshold cycle (Ct)
method. Ampliﬁcation of SLC19A3 transcripts from small intestinal
enteroids was performed as recently described83 with relative gene
expression normalized to β actin. HNF4a, HNFg, and SMAD4 gene
expression was determined by TaqMan (Thermo Fisher) using validated primer and probe sets. Primers and TaqMan probes used in this
study are listed in Supplemental Table 2.

Villin. Differentiated LT-treated and control enteroid monolayers were
lysed using NE-PERTM nuclear and cytoplasmic extraction reagents
(Thermo Scientiﬁc). Cell membrane pellets were solubilized in PBS
containing 1% Triton X-100 supplemented with a protease inhibitor
cocktail (PierceTM protease inhibitor mini, Thermo Scientiﬁc). Equal
amounts of total protein were loaded on a 4–20% gradient SDS-PAGE
gel (Mini Protean TGX, Bio-Rad), then blotted onto nitrocellulose
membranes and probed with anti-villin mouse monoclonal antibody
(1:1000; Cat# SC-66022; Santa Cruz Biotechnology) followed by
detection with HRP-conjugated anti-mouse secondary antibody
(1:1000; Cat# 7076 S; Cell Signaling Technology). Blots were developed with Clarity Western ECL substrate (Bio-Rad) and imaged with a
c600 imaging system (Azure Biosystems). Relative Villin expression
signals were then analyzed with respect to corresponding Coomassiestained gel using ImageJ analysis software.

Transcriptional reporter assays

Thiamin uptake

To assess the impact of LT on HNF4-mediated transcription, pTR104
(GeneCopoeia) carrying six copies of the HNF4 transcriptional
response element upstream of a secreted Gaussia luciferase (Gluc)
reporter gene was transfected (FuGENE, Promega) into conﬂuent
Caco-2 cells. Media (EMEM, ATCC) were exchanged 24 h after transfection, and after an additional 24 h, baseline samples of media were
removed from each well and stored at −80 °C. Wells were then treated
with a heat-labile toxin (100 ng/ml) overnight (16 h). At the end of
treatment cell culture supernatants media were transferred to blackwalled microplates (Greiner 655086) and processed as directed
(Secrete-Pair Luminescence, GeneCopoeia, Inc. Rockville, MD), followed by luminescence detection (Synergy H1, BioTek). Data were
expressed as Relative Light Units (RLU) before and after treatment
with LT.
SMAD4-mediated transcription was assessed by transient transfection of Caco-2 cells with the SBE4-luc plasmid containing four
copies of the SMAD4 transcriptional response element 5’-GTCTAGAC-3'84.
Following treatment with overnight treatment with LT, cells were
resuspended in 80 µl of EMEM media and mixed with an equal volume
of ONEGLO EX Reagent (Nano-Glo® Dual-Luciferase® Reporter Assay
System, Promega) for 20 min on an orbital shaker at 300 rpm, then
read on the luminometer as above.

Initial rates (30 min; at 37 °C) of carrier-mediated thiamin uptake were
examined in LT-treated (100 ng/ml; overnight) and untreated control
differentiated small intestinal enteroid monolayers incubated in
Krebs–Ringer buffer (pH 7.4) containing [3H]-thiamin (15 nM). Enteroid
monolayers were then washed with ice-cold Krebs–Ringer buffer, followed by lysis with NaOH and neutralization with 10 N HCl. The
radioactive content was counted using a liquid scintillation counter as
described previously83. Uptake of thiamin by its respective and distinct
carrier-mediated mechanism was determined by subtracting uptake of
[3H]-thiamin in the presence of a high pharmacological concentration
(1 mM) of unlabeled thiamin from uptake in their absence; all uptake
data points were calculated relative to total protein content (in milligrams) of the different preparations and presented as a percentage
relative to simultaneously performed controls.

Quantitative real-time PCR

Immunoblotting
SLC19A3, SP1. Total protein was extracted from LT toxin-treated
(100 ng/ml) human differentiated enteroid monolayers (235D line) and
untreated control using radioimmunoprecipitation assay (RIPA) buffer
(Sigma) containing protease inhibitor cocktail. An equal amount
(∼25 μg) of the proteins were loaded on a NuPAGE 4-12% Bris–Tris
gradient gels (Invitrogen) as previously described83, then blotted onto
polyvinylidene diﬂuoride (PVDF) membranes and probed with antiSLC19A3 (1:1000; Cat# 13407-1-AP; Proteintech), or anti-SP1 (1:1000;
Cat# ab124804; Abcam) antibodies and together with anti-beta actin
(1:3000; Cat# sc-47778) primary antibodies. The speciﬁcity of the
SLC19A3 antibodies was validated in our laboratory previously using

Nature Communications | (2022)13:6886

Confocal microscopy
Cell monolayers were ﬁxed with 2% paraformaldehyde for 30 min at
37 °C and then washed 3× with PBS prior to blocking with 1% BSA in PBS
for 1 h at room temperature. Villin expression was detected using 1:100
dilution of anti-villin antibodies raised in mice (Santa Cruz Biotechnology) for 1 h at room temperature, followed by additional 1 h
incubation with 1:200 dilution of ﬂuorescence-tagged goat anti-mouse
IgG Alexa Fluor 488 (Thermo Fisher) (Supplemental Table 5). Cell
membranes were stained with 1:2000 dilution of CellMask orange
(Invitrogen) and nuclei were counterstained with DAPI (1:1000) and
mounted on glass slides using Prolong Gold antifade reagent (Invitrogen). Images were captured and analyzed on a Nikon C2 confocal
microscope equipped with NIS-Elements AR 5.11.01 software (Nikon).

Electron microscopy
For ultrastructural analyses, in vitro-grown differentiated polarized
monolayers of human ileal enteroid samples, as well as mouse intestinal biopsy samples, were ﬁxed in 2% paraformaldehyde/2.5% glutaraldehyde (Ted Pella, Inc., Redding, CA) in 100 mM sodium cacodylate
buffer, pH 7.2 for 2 h at room temperature and then overnight at 4 °C.
Samples were washed in sodium cacodylate buffer and postﬁxed in 2%
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osmium tetroxide (Ted Pella, Inc) 1 h at room temperature. Samples
were then rinsed in dH20, dehydrated in a graded series of ethanol, and
embedded in Eponate 12 resin (Ted Pella, Inc.). Sections of 95 nm were
cut with a Leica Ultracut UCT ultramicrotome (Leica Microsystems
Inc., Bannockburn, IL), stained with uranyl acetate and lead citrate, and
viewed on a JEOL 1200 EX transmission electron microscope (JEOL USA
Inc., Peabody, MA) equipped with an AMT 8 megapixel digital camera
and AMT Image Capture Engine V602 software (Advanced Microscopy
Techniques, Woburn, MA). Images were analyzed using ImageJ software for microvilli length and structures.
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milk, the dam was separated from the litter ~2 h prior to milking.
Oxytocin (Sigma O3251), 0.002 IU/g, was injected IP to stimulate milk
production, followed by collection via pipette tip. Anti-LT immune
responses in maternal fecal extracts and breast milk, and stomach
contents and sera of neonates (male and female) were assessed by GM1
ganglioside89 kinetic ELISA90 for anti-LT IgA and IgG, using plates
coated with GM1 (Sigma G7641), as previously described91.

Reporting summary
Further information on research design is available in the Nature
Portfolio Reporting Summary linked to this article.

Identiﬁcation of potential transcription factor target sites
The CREB targets database65 (http://natural.salk.edu/CREB/) was used
to identify potential categorical CRE full (TGACGTCA) or half (TGACG/
CGTCA) sites within the promotor regions of genes modulated by the
heat-labile toxin. Following previously described protocol23, 5 kilobase
upstream sequences from each human gene were retrieved from
Ensembl86 and were searched for the CREB-binding sites TGACGTCA
and TGACGTAA (and their reverse complements), based on sequences
retrieved from the TRANSFAC87 database (matrix ID: V$CREB_01).
CREB sequence matches were identiﬁed in the upstream sequences of
1,302 genes. WebGestalt42 was used for overall functional enrichment
of potential transcription factor binding sequences upstream from
genes that were signiﬁcantly (p < 0.05) up- and down-regulated in both
Caco-2 cells and enteroids.

Suckling mouse challenge studies
Studies in mice were performed under protocol 20-0438 approved by
the Washington University in Saint Louis Institutional Animal Care and
Use Committee. In neonatal mouse challenge studies, 3-day-old CD-1
mice (male and female) were inoculated with wild-type ETEC (H10407),
isogenic toxin deletion mutants, or sterile PBS (sham negative controls). Inocula were prepared from frozen glycerol stocks maintained
at −80 °C grown overnight (~16 h) in 2 ml Luria Bertani (LB) broth in a
shaking incubator (at 37 °C, 225 rpm). Cultures were then diluted 1:100
in 20 ml of fresh LB, grown for an additional 2 h, and bacteria were
harvested by centrifugation (6000 rpm, 5 min at 4 °C). Pellets were
then washed once in ice-cold sterile PBS, then resuspended to a density
of ~1 × 105 colony forming units (CFU) per 20 µl inoculum. CFU in each
inoculum were determined by plating serial dilutions LB-agar plates.
Mice were then inoculated with ETEC directly into the stomach
through the abdominal wall using a 31 g insulin needle. Following
infection, mice were marked with tattoo ink to deﬁne groups and
returned to the cage. Seven days post-infection, mice were sacriﬁced,
and the ileal tissue collected was ﬁxed for microscopy or preserved for
RNA extraction.

Bacterial strain construction
The strains used in these studies are described in Supplementary
Table 1. Strain jf4763 is devoid of all enterotoxins and was constructed
from a previously engineered ST-negative mutant of H10407, jf284888.
Brieﬂy, jf2848 was ﬁrst transformed with pKD46, a lambda red
recombinase helper plasmid with selection on ampicillin.
Jf2848(pKD46) was then transformed with a PCR amplicon generated
with primers _to replace the eltAB genes encoding LT with a spectinomycin resistance cassette resulting in jf4763. The strain was subsequently validated by PCR and by testing supernatants in GM1
ganglioside ELISA to conﬁrm the lack of LT production.

Vaccination and immunologic assessment
Adult female mouse dams were vaccinated intranasally three times at
2-week intervals with 10 µg LT holotoxin in PBS, with the last dose
administered ~2 weeks prior to anticipated delivery. Control mice were
mock vaccinated with PBS. Fecal pellets collected from vaccinated
dams were used to assess mucosal responses to LT. To collect breast

Nature Communications | (2022)13:6886

Data availability
RNAseq data were deposited at the Sequence Read Archive (SRA) on
the NCBI website https://www.ncbi.nlm.nih.gov/sra under BioProject
accession number PRJNA875141. Primary source data and original
images are available on Figshare as detailed in Supplementary Table 6
of the supplementary information.
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